v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Operating activities                
Net loss $ (8,344,165) $ (9,074,261) $ (6,968,282) $ (5,361,720) $ (70,773,374) $ (18,517,308) $ 27,200,000 $ 4,900,000
Adjustments to reconcile to net loss to net cash used in operating activities                
Depreciation and amortization         211,220 122,352    
Stock-based compensation         4,487,003 2,690,081    
Write-off of deferred financing costs 0   0   43,562,847 0    
Beneficial conversion feature on convertible debenture         0 427,796    
Accretion of discount on convertible debenture         0 116,147    
Change in fair value of warrants liability (170,000)   (557,000)   (854,000) (627,228)    
Change in fair value of derivative liability         19,309 0    
Loss on disposal of asset         0 1,349    
Gain on extinguishment of PPP Loan         0 (492,100)    
Noncash lease expense         336,903 2,141    
Change in operating assets and liabilities                
Accounts receivable         818,758 (99,963)    
Inventory         (649,809) (5,126,698)    
Prepaid expenses and other assets         (2,040,485) (4,062,202)    
Accounts payable         (4,070,611) (240,200)    
Accrued expenses         443,491 2,260,833    
Deferred revenue         324,660 66,493    
Net cash used in operating activities         (28,184,088) (23,478,507) (29,200,000) (3,100,000)
Investing activities                
Proceeds from sale of property and equipment         0 7,784    
Purchase of property and equipment         (349,182) 0    
Investments         (1,000,000) 0    
Net cash (used) provided in investing activities         (1,349,182) 7,784    
Financing activities                
Proceeds from Newborn Escrow Account         0 58,184,461    
Redemption of Newborn shares         0 (18,629)    
Issuance costs related to reverse recapitalization and PIPE offering         0 (3,970,657)    
Proceeds from PIPE offering         0 14,250,000    
Repayment of Newborn sponsor loans         0 (487,500)    
Repurchase of common stock from EDF         0 (6,000,000)    
Newborn cash acquired         0 50,206    
Purchase of stock from investor         0 (2,000,000)    
Payment of financing costs         0 (1,000,000)    
Proceeds from forward option put exercise         1,994,073 0    
Proceeds from exercise of pre-funded warrants related to Direct Offering         58 0    
Proceeds from Direct Offering of common stock, net of offering costs         13,069,815 0    
Proceeds from common stock offering, net of offering costs         3,763,494 0    
Payment of finance lease obligations         (7,396) (4,613)    
Proceeds from exercise of stock options         209,280 18,325    
Issuance of Preferred Stock         0 3,138,000    
Net cash provided in financing activities         19,029,324 62,159,593    
Effect of exchange rate on cash         (121,218) 150,547    
Net (decrease) increase in cash and restricted cash         (10,625,164) 38,839,417    
Cash and restricted cash at beginning of year   $ 32,740,520   $ 2,275,895 32,740,520 2,275,895 2,275,895  
Cash and restricted cash at end of period $ 22,115,356   $ 41,115,312   22,115,356 41,115,312 $ 32,740,520 $ 2,275,895
Supplemental Disclosure of Noncash Financing Activity                
Conversion of preferred stock to common stock         0 1,679    
Conversion of debenture and accrued interest to common shares         0 3,999,435    
Conversion of shares due to reverse recapitalization         0 3,383    
Issuance of common stock for merger success fee         0 2,085,299    
Non-cash merger transaction costs         0 2,085,299    
Accrued transaction costs related to reverse recapitalization         0 189,434    
Issuance of private warrants         0 1,253,228    
Forgiveness of PPP Loan         0 492,100    
Issuance of Stonepeak and Evolve warrants         0 30,234,000    
Issuance of Stonepeak and Evolve options         0 12,584,000    
Transfer of Inventory to property and equipment         $ 87,095 $ 0